TITLE:
A Study of DTC in Patients With AIDS and AIDS Related Complex

CONDITION:
HIV Infections

INTERVENTION:
Ditiocarb sodium

SUMMARY:

      To determine if ditiocarb sodium (sodium diethyldithiocarbamate; DTC) restores immune and
      host defense function; if DTC ameliorates the AIDS related complex (ARC) symptoms in
      patients with AIDS and ARC; if DTC prevents progression from ARC to AIDS or progression of
      AIDS; and if DTC prolongs survival in AIDS.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

        Concurrent Medication:

        Allowed:

          -  Zidovudine (AZT).

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following are excluded:

          -  Active opportunistic infection or progressive Kaposi's sarcoma (KS).

          -  Dementia.

          -  Lymphoma.

        Concurrent Medication:

        Excluded within 3 weeks of study entry:

          -  Other experimental AIDS therapy.

        Patients with the following are excluded:

          -  Active opportunistic infection or progressive Kaposi's sarcoma (KS).

        Patients must be either HIV seropositive or have AIDS or AIDS related complex (ARC) and
        have life expectancy of at least 6 months.
      
